Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Robby
    Member
    • Mar 2011
    • 68

    #1

    need help with CNVs

    Hello,

    I have a lots of problems to call CNVs in genome samples (tumor/normal pairs) sequenced with Illumina.

    First I tested CNVnator, but I had already problems with the second step, because I don't know the bin_size (./cnvnator -root file.root -chrom ch1 -his bin_size). I tested with 100, 1000, 1000000, but the program ran in all cases just for chromosome 22 over one week and was still not finished. I asked already in another thread for the bin_size, but unfortunally I didn't receive any answers (http://seqanswers.com/forums/showthr...t=11013&page=2).

    After that I tested CNV-Seq, but I don't understand the output. Especially I don't know the exact position of the CNV and the difference between log2 and cnv.log2 and the difference between p.value and cnv.p.value

    "chr1" 2250641 2250864 159 100 2250752 0.722575091988798 8.10063503680068e-07 77 448 0.964667045392917 3.93033619539229e-35
    "chr1" 2250753 2250976 171 87 2250864 1.02845734551634 3.42115799964058e-11 77 448 0.964667045392917 3.93033619539229e-35
    "chr1" 2250865 2251088 161 71 2250976 1.2347180850891 2.18142864565488e-14 77 448 0.964667045392917 3.93033619539229e-35
    "chr1" 2250977 2251200 107 60 2251088 0.888124717271795 4.18272787914529e-09 77 448 0.964667045392917 3.93033619539229e-35
    I tried to get some help in another thread (http://seqanswers.com/forums/showthread.php?t=16882) => unfortunally no answer.

    Last I tried CNVer, but I can use that tool just for hg18, which doesn't really help me.

    I there any other tool, which you can recommend? Or do you have any ideas/suggestions/help to solve the problems with one of the above mentioned tools?

    I would be really happy about any comments, because I am completly frustrated.

    Thanks a lot in advance.
    Robby
  • samesense
    Junior Member
    • Aug 2010
    • 3

    #2
    Try out ExomeCNV. First, find LOH. Then use LOH regions to determine normal contamination in your tumor sample. Finally, estimate CNVs, using the normal contamination correction.

    Comment

    • Robby
      Member
      • Mar 2011
      • 68

      #3
      thanks for your answer.

      But how do I search for LOH regions in tumor/normal samples? And does ExomeCNV also works for complete genome sequences or do I have to extract the exonic regions before?

      Best regards
      Robby

      Comment

      • samesense
        Junior Member
        • Aug 2010
        • 3

        #4
        The program also does LOH. Follow these instructions. First, find normal tissue SNVs that are heterozygous (you have to determine these SNVs yourself), then make files with the coverage and 'mutant' read counts for these SNVs for tumor and normal tissue. These files are input for the ExomeCNV R LOH functions.

        As for application to whole genomes, I'm not sure.

        Comment

        • clarissaboschi
          Member
          • Apr 2010
          • 63

          #5
          The bin size used depends on the coverage of your data, see supplemental material from CNVnator paper. But I have the same doubt. I tested bins of: 100, 120, 150 and 200 bp. My coverage is about 8-15X. With each bin I had a different number of CNVs. I am not sure which one is better...
          Also I do not know if I should filter the results based on the p-value...

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 08-06-2026, 07:41 AM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          31 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          41 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Working...